# Great Point Partners: portfolio, investments and team > Great Point Partners is a private equity based in United States. 17 investments on record, latest Aug 2018. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/great-point-partners (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Great Point Partners Last cheque observed Aug 2018. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Email Quiet New fund $432M, Apr 2022 Private equity Seed Series A Series B Medical Device In Vitro Diagnostics Health Follow Great Point Partners and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fgreat-point-partners) Cheques on record **0%** of best year **0** **cheques in 12 months**, 17 on record Since the last cheque **2985** days **00** hrs **00** min **00** sec Median round **$4.3M** Rounds led **0 of 17** Sole investor **5 rounds** Exits **5 from the portfolio** Mostly in **United States, 94%** Pitch Great Point Partners ## Great Point Partners highlights - 01 17 rounds on record - 02 Mostly Venture and Series A: 88% of its rounds - 03 Sole investor in 5 rounds, median $10M - 04 5 exits from the portfolio ## What they do > lower middle market growth buyout funds investing in private health care companies From their own website - **Type:** Private equity (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B - **Sectors:** Medical Device In Vitro Diagnostics Health - **Based in:** Harrison, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **17 appearances** - **2018** 1 round - **Aug** **[Nebula Genomics](https://millionrounds.com/company/nebula-genomics)** Seed · US · FinSMEs **$4.3M** With 10 others - **2014** 1 round - **Feb** **[Aurinia Pharmaceuticals](https://millionrounds.com/company/aurinia-pharmaceuticals)** CA **$52M** With 8 others - **2013** 4 rounds - **Dec** **[Bovie Medical](https://millionrounds.com/company/bovie-medical)** Venture · US **$7.0M** Sole investor - **Nov** **[Health Revenue Assurance Holdings](https://millionrounds.com/company/health-revenue-assurance-holdings)** Venture · US · floridaventuresourcing.com **$5.4M** Sole investor - **Nov** **[Ocera Therapeutics](https://millionrounds.com/company/ocera-therapeutics)** Venture · US · fiercebiotech.com **$28M** With 7 others - **Jun** **[iVantage Health Analytics](https://millionrounds.com/company/ivantage-health-analytics)** Growth · US · pehub.com **$10M** Sole investor - **2012** 1 round - **Aug** **[Connecture](https://millionrounds.com/company/connecture)** Venture · US · finsmes.com **$20M** With 1 other - **2011** 2 rounds - **May** **[Biodel](https://millionrounds.com/company/biodel)** Venture · US · masshightech.com **$30M** With 1 other - **Mar** **[Cytovance Biologics](https://millionrounds.com/company/cytovance-biologics)** Venture · US · cytovance.com **$23M** Sole investor - **2010** 3 rounds - **Mar** **[Solta Medical](https://millionrounds.com/company/solta-medical)** Venture · US · deals.venturebeat.com **$4.8M** With 1 other - **Mar** **[BioSante Pharmaceuticals](https://millionrounds.com/company/biosante-pharmaceuticals)** Venture · US · biosantepharma.com **$18M** With 1 other - **Jan** **[Solta Medical](https://millionrounds.com/company/solta-medical)** Venture · US · fis.dowjones.com **$17M** With 1 other - **2008** 1 round - **Sept** **[APT Pharmaceuticals](https://millionrounds.com/company/apt-pharmaceuticals)** Series A · US · aptbio.com **$32M** With 6 others - **2007** 2 rounds - **Nov** **[SGX Pharmaceuticals](https://millionrounds.com/company/sgx-pharmaceuticals)** Venture · US · thefreelibrary.com **$25M** With 2 others - **Oct** **[APT Pharmaceuticals](https://millionrounds.com/company/apt-pharmaceuticals)** Series A · US **$22M** With 3 others - **2004** 2 rounds - **Dec** **[Panacos Pharmaceuticals](https://millionrounds.com/company/panacos-pharmaceuticals)** Venture · US **$20M** Sole investor - **Jan** **[Forbes Medi-Tech](https://millionrounds.com/company/forbes-medi-tech)** Series A **$11M** With 1 other An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **3 named** AB **Adam Brian Felsenthal** General Counsel and Chief Compliance Officer i Form ADV JR **Jeffrey Robert Jay** Dr. Jeffrey R. Jay is the Senior Managing Member of Great Point Partners III GP, LLC, the general partner i Filing they signed RM **Ronald Marc Panzier** Chief Operating Officer and Chief Financial Officer i Form ADV We also hold **44** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$1.8B** assets it manages Oct 2026 **Registered** investment adviser full reporting to the SEC - **Legal name:** Great Point Partners, LLC - **SEC number:** CRD 158423 Funds on its Form ADV **20** private funds, **$1.9B** in gross assets · filed Oct 2024 Private equity **18** Hedge **2** - Great Point Partners IV, L.P. *Private equity* 145 investors $535M - Biomedical Value Fund, L.P. *Hedge* 94 investors $516M - Biomedical Offshore Value Fund, LTD. *Hedge* 83 investors $336M - Great Point Partners III, L.P. *Private equity* 109 investors $291M - Great Point Partners II, L.P. *Private equity* 103 investors $66M - Great Point Partners III-A, L.P. *Private equity* 24 investors $51M - GPP III - PCM, LLC *Private equity* 32 investors $31M - GPP - CF I, L.P. *Private equity* 62 investors $30M - GPP III - Ephicacy, LLC *Private equity* 25 investors $21M - Great Point Partners II-A, L.P. *Private equity* 16 investors $20M And 10 more on the filing. ## Exits from the portfolio Companies it backed that were later bought or listed **5 in all** **[iVantage Health Analytics](https://millionrounds.com/company/ivantage-health-analytics)** Bought by The Chartis Group **Undisclosed** Nov 2015 **[Cytovance Biologics](https://millionrounds.com/company/cytovance-biologics)** Bought by [Hepalink](https://millionrounds.com/fund/hepalink) **$206M** Aug 2015 **[Solta Medical](https://millionrounds.com/company/solta-medical)** Bought by Valeant Pharmaceuticals International **$250M** Dec 2013 **[Forbes Medi-Tech](https://millionrounds.com/company/forbes-medi-tech)** Bought by Pharmachem Laboratories **Undisclosed** Aug 2010 **[SGX Pharmaceuticals](https://millionrounds.com/company/sgx-pharmaceuticals)** Bought by [Eli Lilly](https://millionrounds.com/fund/eli-lilly) **$66M** Jul 2008 An exit counts when it came after the firm's first round in the company. From historical deal records. New fund on file **$432M** raised in Apr 2022 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Seed Series A Series B Median round joined **$4.3M** the round, not its cheque Alone, median **$10M** Led 0 of 17 rounds **0%** - **Sole investor:** 5 rounds - **Last cheque:** Aug 2018 - **Exits:** 5 from the portfolio Rounds by stage said on their site - Venture *11* - Series A said *3* - Growth *1* - Seed said *1* - Series B said *-* Cheques by year Led Joined 2004 2018 Often in the room with - [Vivo Ventures](https://millionrounds.com/fund/vivo-ventures) 3 - [Charter Life Sciences](https://millionrounds.com/fund/charter-life-sciences) 2 - [InterWest Partners](https://millionrounds.com/fund/interwest-partners) 2 - [Longitude Capital](https://millionrounds.com/fund/longitude-capital) 2 - [OrbiMed](https://millionrounds.com/fund/orbimed) 2 - [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) 2 **Pitching Great Point Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Great Point Partners. A count of rooms they were both in, not a relationship either has claimed. [**Vivo Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/vivo-ventures)[**Charter Life Sciences** VC firm **2** rounds together](https://millionrounds.com/fund/charter-life-sciences)[**InterWest Partners** VC firm **2** rounds together](https://millionrounds.com/fund/interwest-partners)[**Longitude Capital** VC firm **2** rounds together](https://millionrounds.com/fund/longitude-capital)[**OrbiMed** Private equity **2** rounds together](https://millionrounds.com/fund/orbimed)[**RA Capital Management** Private equity **2** rounds together](https://millionrounds.com/fund/ra-capital-management)[**Three Arch Partners** Growth equity **2** rounds together](https://millionrounds.com/fund/three-arch-partners)[**Versant Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/versant-ventures) ## Recently backed The latest companies Great Point Partners put money into. [**Nebula Genomics** $4.3M · Aug 2018](https://millionrounds.com/company/nebula-genomics) ## Quick answers about Great Point Partners ### What does Great Point Partners invest in? Great Point Partners invests most often at Venture and Series A (88% of the rounds on record), in sectors such as Medical Device, In Vitro Diagnostics and Health. ### How active is Great Point Partners? 17 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2018. ### What has Great Point Partners invested in recently? Its most recent investments on record: Nebula Genomics (Seed, Aug 2018). ### How big are Great Point Partners's cheques? The median round it joins is $4.3M. ### Does Great Point Partners lead rounds? Rarely, if at all: none of its 17 investments on record names it as the lead. ### Where does Great Point Partners invest? Most of the companies it backs are in the United States (94%) and Canada (6%). ### Is Great Point Partners investing now? No investments in the last 12 months; the latest was in Aug 2018. ### Who does Great Point Partners invest alongside? Most often Vivo Ventures (3 rounds together), Charter Life Sciences (2 rounds together) and InterWest Partners (2 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=great-point-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=great-point-partners)